Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Cell Tissue Res ; 379(3): 635-645, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31788759

ABSTRACT

In human, the use of freshly recovered granulosa cells for experiments remains difficult. Because of the single use of human cells, the experiments cannot be repeated, and no additional conditions can be tested afterwards with the cells of the same patient. Therefore, granulosa cell cryopreservation could be a good alternative to keep part of these cells for later controls or experiments. The aim of this study is to compare the responsiveness to FSH of fresh and frozen-thawed human primary granulosa-lutein cells (hGLC) and determine if cryopreserved granulosa cells can be used in place of fresh cells. Two cryopreservation methods were also compared: a conventional versus a simplified freezing method. This experimental study was undertaken at Igyxos S.A., Nouzilly, France. Seventy women undergoing oocyte retrieval at the IVF Unit from Bretonneau University Hospital (Tours, France) were recruited in 2016. Fresh and frozen-thawed hGLC were cultured for 7 days and then stimulated by r-FSH for 48 h. To assess r-FSH efficacy and potency, extracellular cAMP accumulated in the supernatant for each stimulation point was measured. We demonstrated that hGLC remain responsive to FSH stimulation after freezing-thawing and 7 days of pre-culture. They are able to secrete cAMP with a similar EC50 value as fresh hGLC, but FSH efficacy is lowered. As our study did not show any significant difference between the two freezing methods concerning the sensitivity of hGLC to FSH, hGLC could be cryopreserved with the simplified freezing method without taking up too much time for IVF laboratories.


Subject(s)
Cryopreservation/methods , Gonadotropins/pharmacology , Granulosa Cells/cytology , Granulosa Cells/drug effects , Cells, Cultured , Female , Humans
2.
Article in English | MEDLINE | ID: mdl-30833928

ABSTRACT

Gonadotropins are essential for reproduction control in humans as well as in animals. They are widely used all over the world for ovarian stimulation in women, spermatogenesis stimulation in men, and ovulation induction and superovulation in animals. Despite the availability of many different preparations, all are made of the native hormones. Having different ligands with a wide activity range for a given receptor helps better understand its molecular and cellular signaling mechanisms as well as its physiological functions, and thus helps the development of more specific and adapted medicines. One way to control the gonadotropins' activity could be the use of modulating antibodies. Antibodies are powerful tools that were largely used to decipher gonadotropins' actions and they have shown their utility as therapeutics in several other indications such as cancer. In this review, we summarize the inhibitory and potentiating antibodies to gonadotropins, and their potential therapeutic applications.

3.
FEBS J ; 283(3): 498-509, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26607765

ABSTRACT

Papillon-Lefèvre syndrome (PLS) (OMIM: 245000) is a rare disease characterized by severe periodontitis and palmoplantar keratoderma. It is caused by mutations in both alleles of the cathepsin C (CatC) gene CTSC that completely abrogate the proteolytic activity of this cysteine proteinase. Most often, a genetic analysis to enable early and rapid diagnosis of PLS is unaffordable or unavailable. In this study, we tested the hypothesis that active CatC is constitutively excreted and can be easily traced in the urine of normal subjects. If this is true, determining its absence in the urine of patients would be an early, simple, reliable, low-cost and easy diagnostic technique. All 75 urine samples from healthy control subjects (aged 3 months to 80 years) contained proteolytically active CatC and its proform, as revealed by kinetic analysis and immunochemical detection. Of the urine samples of 31 patients with a PLS phenotype, 29 contained neither proteolytically active CatC nor the CatC antigen, so that the PLS diagnosis was confirmed. CatC was detected in the urine of the other two patients, and genetic analysis revealed no loss-of-function mutation in CTSC, indicating that they suffer from a PLS-like condition but not from PLS. Screening for the absence of urinary CatC activity soon after birth and early treatment before the onset of PLS manifestations will help to prevent aggressive periodontitis and loss of many teeth, and should considerably improve the quality of life of PLS patients.


Subject(s)
Cathepsin C/urine , Papillon-Lefevre Disease/diagnosis , Papillon-Lefevre Disease/urine , Adolescent , Adult , Aged , Aged, 80 and over , Cathepsin C/genetics , Cathepsin C/metabolism , Child , Child, Preschool , Female , Healthy Volunteers , Humans , Infant , Male , Middle Aged , Phenotype , Young Adult
4.
Curr Protoc Protein Sci ; Chapter 29: 29.3.1-29.3.22, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22294328

ABSTRACT

Functional characterization of G protein-coupled receptors is essential to ascertain the suitability of a protein target for downstream studies and to help develop optimal expression and isolation procedures. Radioligand binding analysis is a well-established technique, which allows direct measurement of the amount of functional receptor in a sample. It can be readily applied to both membrane-bound and soluble receptor samples and is an ideal method for monitoring the amount of functional protein at each stage in the expression and isolation process. This unit presents protocols for the radioligand binding analysis of the human adenosine A(2a) receptor and provides examples of how these assays can be used at several stages to help optimize expression, solubilization, and isolation procedures.


Subject(s)
Radioligand Assay/methods , Receptor, Adenosine A2A/chemistry , Cell Membrane/chemistry , Detergents/chemistry , Humans , Pichia/chemistry , Protein Stability , Quality Control , Radioligand Assay/standards , Receptor, Adenosine A2A/analysis , Recombinant Proteins/chemistry , Recombinant Proteins/isolation & purification , Reproducibility of Results , Solubility , Structure-Activity Relationship
5.
Br J Pharmacol ; 161(6): 1343-50, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20804495

ABSTRACT

UNLABELLED: BACKGROUND AND PURPOSE; The two phenylpiperidines, OSU6162 and ACR16, have been proposed as novel drugs for the treatment of brain disorders, including schizophrenia and Huntington's disease, because of their putative dopamine stabilizing effects. Here we evaluated the activities of these compounds in a range of assays for the D(2) dopamine receptor in vitro. EXPERIMENTAL APPROACH: The affinities of these compounds for the D(2) dopamine receptor were evaluated in competition with [(3) H]spiperone and [(3) H]NPA. Agonist activity of these compounds was evaluated in terms of their ability to stimulate [(35) S]GTPγS binding. KEY RESULTS: Both compounds had low affinities for inhibition of [(3) H]spiperone binding (pK(i) vs. [(3) H]spiperone, ACR16: <5, OSU6162: 5.36). Neither compound was able to stimulate [(35) S]GTPγS binding when assayed in the presence of Na(+) ions, but if the Na(+) ions were removed, both compounds were low-affinity, partial agonists (E(max) relative to dopamine: ACR16: 10.2%, OSU6162:54.3%). Schild analysis of the effects of OSU6162 to inhibit dopamine-stimulated [(35) S]GTPγS binding indicated Schild slopes of ∼0.9, suggesting little deviation from competitive inhibition. OSU6162 was, however, able to accelerate [(3) H]NPA dissociation from D(2) dopamine receptors, indicating some allosteric effects of this compound. CONCLUSIONS AND IMPLICATIONS: The two phenylpiperidines were low-affinity, low-efficacy partial agonists at the D(2) dopamine receptor in vitro, possibly exhibiting some allosteric effects. Comparing their in vitro and in vivo effects, the in vitro affinities were a reasonable guide to potencies in vivo. However, the lack of in vitro-in vivo correlation for agonist efficacy needs to be further addressed. LINKED ARTICLES: This article is part of a themed section on Analytical Receptor Pharmacology in Drug Discovery. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2010.161.issue-6.


Subject(s)
Dopamine Agonists/metabolism , Piperidines/pharmacology , Receptors, Dopamine D2/agonists , Receptors, Dopamine D2/metabolism , Animals , CHO Cells , Cricetinae , Cricetulus , Dopamine Agonists/administration & dosage , Dopamine Agonists/pharmacology , Humans , Piperidines/administration & dosage , Piperidines/metabolism , Protein Binding/drug effects , Protein Binding/physiology
6.
Protein Expr Purif ; 74(1): 80-7, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20438843

ABSTRACT

Recent high resolution structures of modified G-protein coupled receptors (GPCRs) have provided major insight into the mechanisms of receptor-ligand binding. However understanding of the complete mechanism of GPCR function remains limited. This study characterised C-terminally truncated versions of the human adenosine A(2A) receptor (A(2A)R) with a view to producing protein suitable for structural studies. The constructs terminated at residue A316, removing the intracellular C-terminal tail, or V334, producing a C-terminal tail equivalent in length to that of rhodopsin. Higher levels of functional receptor before and after solubilisation were obtained for both C-terminally truncated constructs compared to the wild-type receptor (WT) as assessed by radioligand binding analysis using [(3)H]ZM241385. The construct which yielded the highest level of functional receptor, V334 A(2A)R, was purified in DDM to high homogeneity with a final yield of 2 mg/L. Binding analysis revealed that the purified receptor had a specific activity of 20.2+/-1.2 nmol/mg, close to the theoretical maximum. Pure V334 A(2A)R was resistant to degradation over 15 days when stored at 4 degrees C or 20 degrees C and showed remarkable functional stability when stored at 4 degrees C, retaining 84% of initial functionality after 30 days. This construct is an excellent candidate for structural studies.


Subject(s)
Receptor, Adenosine A2A/isolation & purification , Receptor, Adenosine A2A/metabolism , Cell Line , Cholesterol Esters/metabolism , Detergents , Gene Expression , Humans , Protein Stability , Receptor, Adenosine A2A/genetics , Solubility
7.
J Neurochem ; 112(6): 1442-53, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20050980

ABSTRACT

There is much evidence to suggest that G protein coupled receptors exist as oligomers but the relevance to their function is unclear. We have, therefore, examined the binding of the radiolabelled agonist [(3)H]NPA to membranes of CHO cells expressing the D(2) dopamine receptor in dissociation rate experiments. When [(3)H]NPA dissociation was started by dilution, the dissociation rate in the absence of sodium ions was unaffected by addition of the antagonist/inverse agonist (+)-butaclamol, but was accelerated by addition of agonists e.g. dopamine, suggesting that the receptor was not behaving as a monomer with a single binding site. The very low efficacy partial agonist, aripiprazole provided an intermediate level of acceleration of dissociation. [(3)H]NPA dissociation experiments started by addition of ligands without dilution gave a similar pattern. [(3)H]NPA dissociation could also be accelerated by GTP. Dissociation of [(3)H]NPA in the presence of GTP and dopamine provided a greater acceleration than for either modulator alone, suggesting synergistic effects related to receptor/G protein interaction. When [(3)H]NPA dissociation experiments were performed in the presence of sodium ions, dissociation was faster than in their absence but the rate still depended on the ligand present in the assay. Overall the data cannot be explained by a ternary complex model and are consistent with an oligomeric receptor in which binding of [(3)H]NPA, as an example of an agonist ligand, can be modulated co-operatively by ligands binding elsewhere in the oligomer. Interactions with G proteins also occurs providing further modulation of [(3)H]NPA binding. Both agonists and G proteins are proposed to modulate the oligomer by switching high affinity agonist binding sites to low affinity sites.


Subject(s)
Receptors, Dopamine D2/agonists , Receptors, Dopamine D2/metabolism , Animals , Apomorphine/analogs & derivatives , Apomorphine/pharmacokinetics , Brain/cytology , Brain/drug effects , CHO Cells , Cricetinae , Cricetulus , Dopamine/pharmacology , Dopamine Agonists/pharmacokinetics , Dopamine Antagonists/pharmacology , Dopamine D2 Receptor Antagonists , Dose-Response Relationship, Drug , Protein Binding/drug effects , Radioligand Assay , Rats , Rats, Wistar , Receptors, Dopamine D2/drug effects , Tissue Distribution/drug effects , Tritium/pharmacokinetics
8.
Med Sci (Paris) ; 23(1): 75-80, 2007 Jan.
Article in French | MEDLINE | ID: mdl-17212935

ABSTRACT

FSH is the main endocrine control of mammalian reproduction. FSH triggers somatic cells of the gonads which support germ cells metabolically, i.e. Sertoli cells of the seminiferous tubules, and granulosa cells harboring the oocyte, within the ovarian follicle. FSH leads to similar biological responses in both cell types since it stimulates proliferation and differentiation, according to the developmental stage. However, FSH receptor knock-out female mice are infertile, unlike male mice. Hence, FSH is not equally important in both sexes. Nevertheless, does FSH induce distinct signalling mechanisms in its target cells ? Here, we compare the signalling mechanisms induced by FSH in ovarian and testicular physiology.


Subject(s)
Follicle Stimulating Hormone/physiology , Reproduction/physiology , Amino Acid Substitution , Animals , Cell Division/physiology , Follicle Stimulating Hormone/deficiency , Follicle Stimulating Hormone/genetics , Humans , Male , Mice , Mice, Knockout , Mutation , Sex Characteristics , Signal Transduction
9.
J Endocrinol ; 190(2): 341-50, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16899567

ABSTRACT

FSH-receptor (FSH-R) signaling is regulated by agonist-induced desensitization and internalization. It has been shown, in a variety of overexpression systems, that G protein-coupled receptor kinases (GRKs) phosphorylate the activated FSH-R, promote beta-arrestin recruitment and ultimately lead to internalization. The accuracy of this mechanism has not yet been demonstrated in cells expressing these different molecules at physiological levels. Using sucrose gradient fractionation, we show that FSH induces the recruitment of the endogenous GRK 2 and beta-arrestin 1/2 from the cytoplasm to the plasma membrane of rat primary Sertoli cells. As assessed by ligand binding, the FSH-R was found expressed in the fractions where GRK 2 and beta-arrestins were recruited upon FSH treatment. In addition, the endogenous beta-arrestin 1 was found dephosphorylated in an agonist-dependent manner. Finally, a significant FSH-binding activity was co-immunoprecipitated with the endogenous beta-arrestins from agonist-stimulated but not from untreated Sertoli cell extracts. This FSH-R interaction with beta-arrestins was sustained for up to 30 min. In conclusion, our data strongly suggest that the GRK/beta-arrestin machinery plays a physiologically relevant role in the regulation of the FSH signaling.


Subject(s)
Arrestins/metabolism , Receptors, FSH/metabolism , Receptors, G-Protein-Coupled/metabolism , Sertoli Cells/metabolism , Signal Transduction/physiology , Animals , Cells, Cultured , Follicle Stimulating Hormone/pharmacology , Immunoblotting/methods , Immunoenzyme Techniques , Immunoprecipitation , Male , Phosphorylation , Protease Inhibitors/pharmacology , Protein Binding , Rats , Rats, Wistar , Sertoli Cells/drug effects , Signal Transduction/drug effects , Stimulation, Chemical , beta-Arrestin 1 , beta-Arrestins
10.
Mol Endocrinol ; 20(11): 3014-26, 2006 Nov.
Article in English | MEDLINE | ID: mdl-16887887

ABSTRACT

Classically, the FSH receptor (FSH-R) mediates its effects through coupling to guanine nucleotide-binding protein alpha S subunit (Galpha(s)) and activation of the cAMP/protein kinase A (PKA) signaling pathway. beta-Arrestins are rapidly recruited to the FSH-activated receptor and play key roles in its desensitization and internalization. Here, we show that the FSH-R expressed in HEK 293 cells activated ERK by two temporally distinct pathways dependent, respectively, on Galpha(s)/PKA and beta-arrestins. Galpha(s)/PKA-dependent ERK activation was rapid, transient, and blocked by H89 (a PKA inhibitor), but it was insensitive to small interfering RNA-mediated depletion of beta-arrestins. beta-Arrestin-dependent ERK activation was slower but more sustained and was insensitive to H89. We identified five Ser/Thr residues in the C terminus of the receptor (638-644) as a major phosphorylation site. Mutation of these residues into Ala (5A FSH-R) significantly reduced the stability of FSH-induced beta-arrestin 1 and 2 interaction when compared with the wild-type receptor. As expected, the 5A FSH-R-mediated cAMP accumulation was enhanced, and its internalization was reduced. In striking contrast, the ability of the 5A FSH-R to activate ERK via the beta-arrestin-dependent pathway was increased. G protein-coupled receptor kinase 5 (GRK5) and GRK6 were required for beta-arrestin-dependent ERK activation by both the wild-type and 5A FSH-R. By contrast, GRK2 depletion enhanced ERK activation by the wild-type FSH-R but not by the 5A FSH-R. In conclusion, we demonstrate the existence of a beta-arrestin-dependent, GRK-regulated mechanism for ERK activation by the FSH-R. A phosphorylation cluster in the C terminus of the FSH-R, identified as a site of beta-arrestin recruitment, positively regulated both desensitization and internalization but negatively regulated beta-arrestin-dependent ERK activation.


Subject(s)
Arrestins/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Receptors, FSH/metabolism , Amino Acid Motifs , Amino Acid Sequence , Cells, Cultured , Endocytosis , G-Protein-Coupled Receptor Kinase 2 , Humans , Molecular Sequence Data , Mutant Proteins/metabolism , Phosphorylation , Protein Binding , Protein Interaction Mapping , Protein Structure, Tertiary , Protein Transport , Receptors, FSH/chemistry , Sequence Homology, Amino Acid , Serine/metabolism , Signal Transduction , Threonine/metabolism , beta-Adrenergic Receptor Kinases/metabolism , beta-Arrestin 1 , beta-Arrestins
11.
Reprod Biol Endocrinol ; 4: 33, 2006 Jun 20.
Article in English | MEDLINE | ID: mdl-16787538

ABSTRACT

BACKGROUND: The follicle-stimulating hormone receptor (FSH-R) is a seven transmembrane spanning receptor (7TMR) which plays a crucial role in male and female reproduction. Upon FSH stimulation, the FSH-R activates the extracellular signal-regulated kinases (ERK). However, the mechanisms whereby the agonist-stimulated FSH-R activates ERK are poorly understood. In order to activate ERK, some 7 TMRs require beta-arrestin-and dynamin-dependent internalization to occur, whereas some others do not. In the present study, we examined the ability of the FSH-activated FSH-R to induce ERK phosphorylation, in conditions where its beta-arrestin- and dynamin-mediated internalization was impaired. METHODS: Human embryonic kidney (HEK) 293 cells were transiently transfected with the rat FSH-R. Internalization of the FSH-R was manipulated by co-expression of either a beta-arrestin (319-418) dominant negative peptide, either an inactive dynamin K44A mutant or of wild-type beta-arrestin 1 or 2. The outcomes on the FSH-R internalization were assayed by measuring 125I-FSH binding at the cell surface when compared to internalized 125I-FSH binding. The resulting ERK phosphorylation level was visualized by Western blot analysis. RESULTS: In HEK 293 cells, FSH stimulated ERK phosphorylation in a dose-dependent manner. Co-transfection of the beta- arrestin (319-418) construct, or of the dynamin K44A mutant reduced FSH-R internalization in response to FSH, without affecting ERK phosphorylation. Likewise, overexpression of wild-type beta-arrestin 1 or 2 significantly increased the FSH-R internalization level in response to FSH, without altering FSH-induced ERK phosphorylation. CONCLUSION: From these results, we conclude that the FSH-R does not require beta-arrestin- nor dynamin-mediated internalization to initiate ERK phosphorylation in response to FSH.


Subject(s)
Arrestins/physiology , Dynamins/physiology , Endocytosis/physiology , Extracellular Signal-Regulated MAP Kinases/metabolism , Follicle Stimulating Hormone/physiology , Receptors, FSH/metabolism , Animals , Arrestins/genetics , Cell Line , Cell Membrane/metabolism , Dose-Response Relationship, Drug , Dynamins/genetics , Follicle Stimulating Hormone/administration & dosage , Follicle Stimulating Hormone/metabolism , Follicle Stimulating Hormone/pharmacology , Genes, Dominant , Humans , Mutation , Phosphorylation/drug effects , Rats , Receptors, FSH/drug effects , Transfection , beta-Arrestin 1 , beta-Arrestins
12.
Mol Endocrinol ; 19(7): 1812-20, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15774499

ABSTRACT

FSH is a major hormonal input that drives Sertoli cells to their fully differentiated function in male reproduction. It is a physiologically important issue to define how FSH mediates its effects at the cellular level to regulate gene expression. FSH biological activities are transduced via a seven-spanned transmembrane receptor, the FSH-R, primarily leading to cAMP-dependent protein kinase A (PKA) activation and cAMP response element binding protein-mediated transcriptional responses. Nevertheless, the intracellular mechanisms interacting with PKA to control Sertoli cell differentiation by FSH are still incompletely defined. Here, we report that, in primary cultures of Sertoli cells isolated from prepubertal rats, FSH enhanced p70S6K enzymatic activity, in a PKA-dependent manner. p70S6K was constitutively phosphorylated on Thr 389, in a manner sensitive to inhibitors of phosphatidyl-inositide-3 kinase and mammalian target of rapamycin. But FSH could not enhance p70S6K phosphorylation on Thr 389. Rather, the hormone induced the dephosphorylation of Thr 421/Ser 424, located in the autoinhibitory domain of p70S6K, in a PKA-dependent manner. Consistently, FSH-induced phosphorylation of the S6 ribosomal protein, a cellular substrate of p70S6K, required PKA activity. In conclusion, these results show that FSH triggers unexpected regulations of p70S6K by dephosphorylation of Thr 421/Ser 424 mediated by PKA, and stimulates S6 phosphorylation, in Sertoli cells.


Subject(s)
Cyclic AMP-Dependent Protein Kinases/metabolism , Follicle Stimulating Hormone/physiology , Ribosomal Protein S6 Kinases, 70-kDa/metabolism , Sertoli Cells/enzymology , Animals , Enzyme Activation , Follicle Stimulating Hormone/pharmacology , Male , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation , Protein Kinases/drug effects , Rats , Serine/metabolism , Sertoli Cells/drug effects , Sirolimus/pharmacology , TOR Serine-Threonine Kinases , Threonine/metabolism
13.
Curr Pharm Des ; 10(5): 449-69, 2004.
Article in English | MEDLINE | ID: mdl-14965333

ABSTRACT

The testis is devoted to two important tasks: haploid cell production and sexual steroid synthesis. A number of highly sophisticated and unique strategies operate during spermatogenesis, a process crucial for reproduction, heredity and evolution. It is particularly important to decipher the underlying molecular mechanisms whose function can be perverted in pathological situations, such as infertility and testicular cancers, which represent an increasing biomedical issue today. This review summarises the currently available data concerning some key molecular components that are altered or potentially involved in male infertility and testicular tumors, with the aim of defining some common "hot spots". We particularly focused on genetically engineered in vivo models in which testicular functions are altered and we pinpointed to the potential involvement of the targeted genes in testicular pathologies. Those molecular mechanisms peculiar to the male gonad can be envisioned as a basis for the design of novel drugs potentially dedicated to testicular dysfunction.


Subject(s)
Infertility, Male/metabolism , Neoplasms, Germ Cell and Embryonal/metabolism , Testicular Neoplasms/metabolism , Animals , Germ Cells/cytology , Germ Cells/growth & development , Humans , Infertility, Male/pathology , Male , Neoplasms, Germ Cell and Embryonal/pathology , Testicular Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...